首页 > 最新文献

Case Reports in Ophthalmology最新文献

英文 中文
Early Drainage of Macula-Involving Massive Suprachoroidal Haemorrhage Assisted with Recombinant Tissue Plasminogen Activator May Lead to Better Visual Prognosis. 重组组织型纤溶酶原激活剂辅助下早期引流累及黄斑的脉络膜上大出血可改善视力预后。
IF 0.5 Q4 OPHTHALMOLOGY Pub Date : 2025-05-02 eCollection Date: 2025-01-01 DOI: 10.1159/000545290
Mostafa Khalil, Matt Schneiders, Marc Veckeneer, Jozef A Depla, Eric Feron, Shohista Saidkasimova

Introduction: A massive suprachoroidal haemorrhage (SCH) is a devastating complication with significant morbidity and poor visual and anatomic outcome. Conventional management is to observe for 7-14 days before surgical drainage. However, permanent structural changes in the retina can occur within this timeframe. Suprachoroidal injection of recombinant tissue plasminogen activator (TPA) may speed up clot breakdown and aid early surgical drainage. We present a case series of macula-involving massive SCH (MSCH) treated with early drainage aided by recombinant tissue plasminogen activator (r-tPA).

Case presentation: Retrospective case series of 3 patients with macula-involving MSCH treated with suprachoroidal r-tPA within 24 h of bleed and early drainage of SCH within 48 h of r-tPA injection, combined with vitrectomy and tamponade. 100 µg of recombinant TPA was injected into the SCH 24 h following initial injury in all patients. Drainage of the SCH was then performed 6-48 h after the injection of r-tPA. Early drainage was successful and visual improvement was seen in all patients. One patient had a recurrence of SCH but was successfully re-treated.

Conclusion: The technique of r-tPA-assisted early drainage of SCH is safe and has promising potential to restore visual function in patients with macula-involving MSCH. Our small sample would indicate that 100 μg/0.4 mL of r-tPA injected within 24 h of bleed allows surgical drainage of SCH as early as day 2 post initial injury. Larger studies are required to investigate further which patients are likely to benefit from this treatment.

大量脉络膜上出血(SCH)是一种毁灭性的并发症,具有显著的发病率和不良的视觉和解剖结果。常规的处理方法是在手术引流前观察7-14天。然而,视网膜的永久性结构变化可能在这段时间内发生。脉络膜上注射重组组织型纤溶酶原激活剂(TPA)可加速血块分解,有助于早期手术引流。我们报告了一个病例系列,涉及黄斑块状SCH (MSCH)的早期引流辅助重组组织纤溶酶原激活剂(r-tPA)。病例介绍:回顾性分析3例累及黄斑的mscs患者,在出血后24小时内行脉络膜上r-tPA治疗,在注射r-tPA后48小时内早期引流,并联合玻璃体切除和填塞。所有患者均在初始损伤后24 h注射100µg重组TPA。注射r-tPA后6-48 h进行SCH引流。所有患者早期引流成功,视力均有改善。1例SCH复发,但再次成功治疗。结论:r- tpa辅助SCH早期引流技术是安全的,在恢复黄斑累及的mscs患者的视觉功能方面具有广阔的应用前景。我们的小样本表明,在出血24小时内注射100 μg/0.4 mL的r-tPA,可以在初次损伤后第2天手术引流SCH。需要更大规模的研究来进一步调查哪些患者可能从这种治疗中受益。
{"title":"Early Drainage of Macula-Involving Massive Suprachoroidal Haemorrhage Assisted with Recombinant Tissue Plasminogen Activator May Lead to Better Visual Prognosis.","authors":"Mostafa Khalil, Matt Schneiders, Marc Veckeneer, Jozef A Depla, Eric Feron, Shohista Saidkasimova","doi":"10.1159/000545290","DOIUrl":"10.1159/000545290","url":null,"abstract":"<p><strong>Introduction: </strong>A massive suprachoroidal haemorrhage (SCH) is a devastating complication with significant morbidity and poor visual and anatomic outcome. Conventional management is to observe for 7-14 days before surgical drainage. However, permanent structural changes in the retina can occur within this timeframe. Suprachoroidal injection of recombinant tissue plasminogen activator (TPA) may speed up clot breakdown and aid early surgical drainage. We present a case series of macula-involving massive SCH (MSCH) treated with early drainage aided by recombinant tissue plasminogen activator (r-tPA).</p><p><strong>Case presentation: </strong>Retrospective case series of 3 patients with macula-involving MSCH treated with suprachoroidal r-tPA within 24 h of bleed and early drainage of SCH within 48 h of r-tPA injection, combined with vitrectomy and tamponade. 100 µg of recombinant TPA was injected into the SCH 24 h following initial injury in all patients. Drainage of the SCH was then performed 6-48 h after the injection of r-tPA. Early drainage was successful and visual improvement was seen in all patients. One patient had a recurrence of SCH but was successfully re-treated.</p><p><strong>Conclusion: </strong>The technique of r-tPA-assisted early drainage of SCH is safe and has promising potential to restore visual function in patients with macula-involving MSCH. Our small sample would indicate that 100 μg/0.4 mL of r-tPA injected within 24 h of bleed allows surgical drainage of SCH as early as day 2 post initial injury. Larger studies are required to investigate further which patients are likely to benefit from this treatment.</p>","PeriodicalId":9635,"journal":{"name":"Case Reports in Ophthalmology","volume":"16 1","pages":"385-394"},"PeriodicalIF":0.5,"publicationDate":"2025-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12158417/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144274267","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Post-Operative Endophthalmitis following Routine Photorefractive Keratectomy. 常规光屈光性角膜切除术后眼内炎。
IF 0.5 Q4 OPHTHALMOLOGY Pub Date : 2025-04-29 eCollection Date: 2025-01-01 DOI: 10.1159/000546142
Barry Power, Michael Wang, Alexandra Z Crawford, Shanu Subbiah

Introduction: Endophthalmitis is an exceptionally rare but devastating complication following laser corneal refractive surgery.

Case presentation: We present a case of Pseudomonas aeruginosa endophthalmitis following routine myopic photorefractive keratectomy with mitomycin C application. The patient was referred to a tertiary ophthalmic service with severe post-operative infectious keratitis following initial management at another centre and was treated with intensive fortified antibiotics. The eye subsequently developed endophthalmitis with corneal perforation, necessitating urgent pars plan vitrectomy facilitated by a temporary keratoprosthesis and subsequent therapeutic penetrating keratoplasty. During anaesthetic induction, the patient developed anaphylaxis, most likely secondary to succinylcholine. Aggressive posterior positive pressure was encountered intra-operatively, resulting in spontaneous extrusion of the crystalline lens. We postulate that the posterior positive pressure was caused by several factors, including massive inflammation, and fluid shifts secondary to anaphylaxis and its associated management. The positive pressure was successfully managed and a keratoprosthesis was secured, allowing completion of vitrectomy and therapeutic penetrating keratoplasty. At 6-month follow-up, the vision remains at light perception.

Conclusion: Endophthalmitis is an exceptionally rare but devastating complication following laser corneal refractive surgery, and the use of mitomycin C might have contributed to the rapid progression observed in the current case. Our report also highlights that acute anaphylaxis and its management can lead to posterior positive pressure, and measures should be taken to reduce the potential impacts before intraocular surgery and full-thickness incisions are made.

眼内炎是激光角膜屈光手术后非常罕见但具有破坏性的并发症。病例报告:我们报告一例铜绿假单胞菌在常规近视屈光性角膜切除术后并发眼内炎。患者在另一中心接受初步治疗后,因术后严重感染性角膜炎被转诊至三级眼科,并接受强化抗生素治疗。眼球随后发展为眼内炎并角膜穿孔,需要通过临时角膜假体和随后的穿透性角膜移植术进行紧急玻璃体切除术。在麻醉诱导期间,患者出现过敏反应,很可能继发于琥珀酰胆碱。术中遇到严重的后路正压,导致晶状体自发挤压。我们推测后路正压是由多种因素引起的,包括大量炎症、继发于过敏反应的液体移位及其相关的处理。成功控制正压并固定角膜假体,完成玻璃体切除术和治疗性穿透性角膜移植术。随访6个月,视力仍为光感。结论:眼内炎是激光角膜屈光手术后非常罕见但具有破坏性的并发症,丝裂霉素C的使用可能促成了本病例的快速进展。我们的报告还强调急性过敏反应及其处理可导致后眼正压,在眼内手术和全层切口前应采取措施减少潜在的影响。
{"title":"Post-Operative Endophthalmitis following Routine Photorefractive Keratectomy.","authors":"Barry Power, Michael Wang, Alexandra Z Crawford, Shanu Subbiah","doi":"10.1159/000546142","DOIUrl":"10.1159/000546142","url":null,"abstract":"<p><strong>Introduction: </strong>Endophthalmitis is an exceptionally rare but devastating complication following laser corneal refractive surgery.</p><p><strong>Case presentation: </strong>We present a case of <i>Pseudomonas aeruginosa</i> endophthalmitis following routine myopic photorefractive keratectomy with mitomycin C application. The patient was referred to a tertiary ophthalmic service with severe post-operative infectious keratitis following initial management at another centre and was treated with intensive fortified antibiotics. The eye subsequently developed endophthalmitis with corneal perforation, necessitating urgent pars plan vitrectomy facilitated by a temporary keratoprosthesis and subsequent therapeutic penetrating keratoplasty. During anaesthetic induction, the patient developed anaphylaxis, most likely secondary to succinylcholine. Aggressive posterior positive pressure was encountered intra-operatively, resulting in spontaneous extrusion of the crystalline lens. We postulate that the posterior positive pressure was caused by several factors, including massive inflammation, and fluid shifts secondary to anaphylaxis and its associated management. The positive pressure was successfully managed and a keratoprosthesis was secured, allowing completion of vitrectomy and therapeutic penetrating keratoplasty. At 6-month follow-up, the vision remains at light perception.</p><p><strong>Conclusion: </strong>Endophthalmitis is an exceptionally rare but devastating complication following laser corneal refractive surgery, and the use of mitomycin C might have contributed to the rapid progression observed in the current case. Our report also highlights that acute anaphylaxis and its management can lead to posterior positive pressure, and measures should be taken to reduce the potential impacts before intraocular surgery and full-thickness incisions are made.</p>","PeriodicalId":9635,"journal":{"name":"Case Reports in Ophthalmology","volume":"16 1","pages":"353-359"},"PeriodicalIF":0.5,"publicationDate":"2025-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12129440/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144207760","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Case of Melanoma-Associated Retinopathy Presenting with Ocular Symptoms as the Initial Manifestation: A Case Report. 以眼部症状为首发表现的黑色素瘤相关视网膜病变1例
IF 0.5 Q4 OPHTHALMOLOGY Pub Date : 2025-04-26 eCollection Date: 2025-01-01 DOI: 10.1159/000545942
Bo Zhou, Guoqin Li, Shengbo Wang, Fang Zhou, Peng Wu

Introduction: Melanoma-associated retinopathy (MAR) is a distinct subset within the spectrum of retinal-dysfunction disorders. It is triggered by the cross-reaction between circulating antibodies originating from malignant melanoma (MM) and retinal antigens. The timely identification of paraneoplastic retinal diseases is crucial, as it can significantly contribute to the early diagnosis and treatment of underlying malignancies. Currently, increasing awareness of the early clinical manifestations of MAR is essential for clinicians to detect primary or metastatic MMs at an earlier stage.

Case presentation: This report details a case of a patient who initially presented with night blindness and visual field defects as the primary symptoms. Through a comprehensive and systematic examination process, which involved detailed ophthalmological examinations and multidisciplinary diagnostic approaches, esophageal, and cardia MM was ultimately diagnosed. The patient was referred to an external hospital for comprehensive antitumor management, and posttreatment, the patient self-reported a notable improvement compared to the pretreatment state.

Conclusion: The purpose of sharing this case is to clarify the early clinical manifestations of MAR. It is anticipated that this will prompt clinicians to enhance their vigilance and identify primary or metastatic MMs earlier. Early treatment of the primary disease not only has the potential to reduce the risk of irreversible immune-mediated damage to retinal cells but also to improve visual outcomes. This highlights the significance of early diagnosis and intervention in the management of such diseases, providing important reference for clinicians.

黑素瘤相关性视网膜病变(MAR)是视网膜功能障碍谱系中的一个独特子集。它是由恶性黑色素瘤(MM)和视网膜抗原的循环抗体之间的交叉反应引发的。及时识别副肿瘤视网膜疾病是至关重要的,因为它可以显著有助于早期诊断和治疗潜在的恶性肿瘤。目前,提高对MAR早期临床表现的认识对于临床医生早期发现原发性或转移性mm至关重要。病例介绍:本报告详细介绍了一例以夜盲症和视野缺损为主要症状的患者。通过全面系统的检查过程,包括详细的眼科检查和多学科诊断方法,最终诊断出食管和贲门MM。患者转诊至外院接受综合抗肿瘤治疗,治疗后患者自我报告较治疗前状态有明显改善。结论:分享本病例的目的是澄清mar的早期临床表现,期望这将促使临床医生提高警惕,尽早识别原发性或转移性mm。早期治疗原发疾病不仅有可能降低视网膜细胞不可逆转的免疫介导损伤的风险,而且还可以改善视力。这突出了早期诊断和干预在此类疾病管理中的意义,为临床医生提供了重要的参考。
{"title":"A Case of Melanoma-Associated Retinopathy Presenting with Ocular Symptoms as the Initial Manifestation: A Case Report.","authors":"Bo Zhou, Guoqin Li, Shengbo Wang, Fang Zhou, Peng Wu","doi":"10.1159/000545942","DOIUrl":"10.1159/000545942","url":null,"abstract":"<p><strong>Introduction: </strong>Melanoma-associated retinopathy (MAR) is a distinct subset within the spectrum of retinal-dysfunction disorders. It is triggered by the cross-reaction between circulating antibodies originating from malignant melanoma (MM) and retinal antigens. The timely identification of paraneoplastic retinal diseases is crucial, as it can significantly contribute to the early diagnosis and treatment of underlying malignancies. Currently, increasing awareness of the early clinical manifestations of MAR is essential for clinicians to detect primary or metastatic MMs at an earlier stage.</p><p><strong>Case presentation: </strong>This report details a case of a patient who initially presented with night blindness and visual field defects as the primary symptoms. Through a comprehensive and systematic examination process, which involved detailed ophthalmological examinations and multidisciplinary diagnostic approaches, esophageal, and cardia MM was ultimately diagnosed. The patient was referred to an external hospital for comprehensive antitumor management, and posttreatment, the patient self-reported a notable improvement compared to the pretreatment state.</p><p><strong>Conclusion: </strong>The purpose of sharing this case is to clarify the early clinical manifestations of MAR. It is anticipated that this will prompt clinicians to enhance their vigilance and identify primary or metastatic MMs earlier. Early treatment of the primary disease not only has the potential to reduce the risk of irreversible immune-mediated damage to retinal cells but also to improve visual outcomes. This highlights the significance of early diagnosis and intervention in the management of such diseases, providing important reference for clinicians.</p>","PeriodicalId":9635,"journal":{"name":"Case Reports in Ophthalmology","volume":"16 1","pages":"377-384"},"PeriodicalIF":0.5,"publicationDate":"2025-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12140611/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144233302","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Female Simplex Carriers of X-Linked Retinal Dystrophies: A Case Series. x连锁视网膜营养不良的女性单纯性携带者:一个病例系列。
IF 0.5 Q4 OPHTHALMOLOGY Pub Date : 2025-04-26 eCollection Date: 2025-01-01 DOI: 10.1159/000546129
Adrienne Delaney, Kari E Branham, K Thiran Jayasundera, Naheed W Khan, Abigail T Fahim

Introduction: X-linked inherited retinal dystrophies (IRDs) lead to progressive vision loss in affected males and include choroideremia (CHM), X-linked retinitis pigmentosa (XLRP), and X-linked cone-rod dystrophy (XLCORD). Female carriers may be asymptomatic or manifest disease ranging from mild to severe. Due to the variable manifestation of disease in females, some pedigrees can appear autosomal dominant. However, female carriers presenting as simplex probands are rare and X-linked disease may not be suspected in these cases without genetic testing.

Case presentations: Three affected simplex CHM carriers and six affected simplex XLRP or XLCORD carriers due to variants in RPGR (n = 5) or RP2 (n = 1) were included. Best corrected visual acuity, color fundus photos, fundus autofluorescence (FAF), optical coherence tomography, electroretinography, and Goldmann visual fields were collected. X-chromosome inactivation (XCI) ratios were determined for 4 cases. Age of onset ranged from infancy to 43 years, with nyctalopia as the most common presenting symptom. 4 out of 5 cases with RPGR variants presented with cone or cone-rod dystrophies, while the remaining cases presented with rod-cone dystrophy. XCI analysis revealed extreme skewing in 2 cases who both presented with severe disease. 4 out of 7 cases with FAF demonstrated autofluorescence patterns classic for carrier status. The remaining 3 cases had severe disease and corresponding FAF patterns consistent with their severity.

Conclusion: The absence of family history does not preclude X-linked inheritance in females with retinal dystrophies. Multimodal imaging such as FAF and red-free photos should be included in the workup. As new therapeutic strategies are developed for CHM and RPGR-associated retinal degeneration, including gene therapy, it may become increasingly more important to diagnose symptomatic carriers, as it has been previously shown that earlier intervention is more effective in IRD populations.

简介:x连锁遗传性视网膜营养不良(IRDs)导致受影响男性的进行性视力丧失,包括脉络膜血症(CHM)、x连锁色素性视网膜炎(XLRP)和x连锁锥杆营养不良(XLCORD)。女性携带者可能无症状或表现出轻至严重的疾病。由于疾病在女性的可变表现,一些家系可以出现常染色体显性。然而,表现为单纯先证者的女性携带者是罕见的,在这些病例中,如果没有基因检测,可能不会怀疑x连锁疾病。病例介绍:包括三名受影响的单纯型CHM携带者和六名受影响的单纯型XLRP或XLCORD携带者,原因是RPGR (n = 5)或RP2 (n = 1)的变异。收集最佳矫正视力、彩色眼底照片、眼底自身荧光(FAF)、光学相干断层扫描、视网膜电图和Goldmann视野。测定4例患者x染色体失活率(XCI)。发病年龄从婴儿期到43岁不等,以夜盲症为最常见的表现症状。4 / 5的RPGR变异体表现为锥体或锥杆营养不良,其余病例表现为杆状-锥体营养不良。XCI分析显示,在2例均表现为严重疾病的病例中,出现了极端倾斜。7例FAF患者中有4例表现出典型的载体状态的自身荧光模式。其余3例病情严重,FAF类型与其严重程度相符。结论:无家族史不能排除视网膜营养不良女性的x连锁遗传。多模式成像,如FAF和无红色的照片应包括在工作中。随着CHM和rgr相关视网膜变性的新治疗策略的发展,包括基因治疗,诊断有症状的携带者可能变得越来越重要,因为之前已经表明早期干预在IRD人群中更有效。
{"title":"Female Simplex Carriers of X-Linked Retinal Dystrophies: A Case Series.","authors":"Adrienne Delaney, Kari E Branham, K Thiran Jayasundera, Naheed W Khan, Abigail T Fahim","doi":"10.1159/000546129","DOIUrl":"10.1159/000546129","url":null,"abstract":"<p><strong>Introduction: </strong>X-linked inherited retinal dystrophies (IRDs) lead to progressive vision loss in affected males and include choroideremia (CHM), X-linked retinitis pigmentosa (XLRP), and X-linked cone-rod dystrophy (XLCORD). Female carriers may be asymptomatic or manifest disease ranging from mild to severe. Due to the variable manifestation of disease in females, some pedigrees can appear autosomal dominant. However, female carriers presenting as simplex probands are rare and X-linked disease may not be suspected in these cases without genetic testing.</p><p><strong>Case presentations: </strong>Three affected simplex CHM carriers and six affected simplex XLRP or XLCORD carriers due to variants in <i>RPGR</i> (<i>n</i> = 5) or <i>RP2</i> (<i>n</i> = 1) were included. Best corrected visual acuity, color fundus photos, fundus autofluorescence (FAF), optical coherence tomography, electroretinography, and Goldmann visual fields were collected. X-chromosome inactivation (XCI) ratios were determined for 4 cases. Age of onset ranged from infancy to 43 years, with nyctalopia as the most common presenting symptom. 4 out of 5 cases with <i>RPGR</i> variants presented with cone or cone-rod dystrophies, while the remaining cases presented with rod-cone dystrophy. XCI analysis revealed extreme skewing in 2 cases who both presented with severe disease. 4 out of 7 cases with FAF demonstrated autofluorescence patterns classic for carrier status. The remaining 3 cases had severe disease and corresponding FAF patterns consistent with their severity.</p><p><strong>Conclusion: </strong>The absence of family history does not preclude X-linked inheritance in females with retinal dystrophies. Multimodal imaging such as FAF and red-free photos should be included in the workup. As new therapeutic strategies are developed for CHM and <i>RPGR</i>-associated retinal degeneration, including gene therapy, it may become increasingly more important to diagnose symptomatic carriers, as it has been previously shown that earlier intervention is more effective in IRD populations.</p>","PeriodicalId":9635,"journal":{"name":"Case Reports in Ophthalmology","volume":"16 1","pages":"395-405"},"PeriodicalIF":0.5,"publicationDate":"2025-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12162115/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144282458","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metastatic Cutaneous Melanoma Presenting with Choroidal Metastasis Mimicking Lymphoma: A Case Report. 以脉络膜转移模拟淋巴瘤为表现的转移性皮肤黑色素瘤1例报告。
IF 0.5 Q4 OPHTHALMOLOGY Pub Date : 2025-04-24 eCollection Date: 2025-01-01 DOI: 10.1159/000544926
Laura E Drew-Bear, Allison Drummond, Crystal Truong, Komal Desai

Introduction: Approximately 5% of patients with cutaneous melanoma develop distant metastases, and very rarely, can involve the eye and orbit. This case report discusses a patient with an unusual presentation of choroidal metastasis secondary to cutaneous melanoma.

Case presentation: A 76-year-old man with a past medical history of cutaneous melanoma on the right shoulder status post radiation presented to the ocular oncology clinic with a 3-month history of decreased vision, occasional pain, and floaters in the right eye. Initial examination revealed a visual acuity of hand motion in the right eye, intraocular pressure of 5 mm Hg, and no view to the fundus due to vitreous hemorrhage. B-scan did not show a retinal tear, retinal detachment, or intraocular tumor. The patient underwent pars plana vitrectomy of the right eye where massive choroidal thickening with subretinal yellow deposits obstructing the optic nerve head was seen, initially concerning lymphoma. On postoperative week one, visual acuity remained hand motion and the fundus exam showed clear vitreous and retinal/choroidal infiltrates obscuring the optic nerve and macula. Repeat B-scan showed retinal and choroidal thickening with exudates. Cytology results from surgery later revealed malignant cells consistent with melanoma. The patient underwent ocular radiation but eventually progressed to no light perception visual acuity. He is currently under observation with the goal of palliative care.

Conclusion: This case highlights the importance of maintaining a high level of suspicion for metastasis in the setting of melanoma history even when presentation can be atypical. Early recognition of choroidal metastasis allows for timely intervention, improving the chances of preserving vision.

简介:大约5%的皮肤黑色素瘤患者发生远处转移,很少累及眼睛和眼眶。这个病例报告讨论了一个不寻常的表现脉络膜转移继发于皮肤黑色素瘤的病人。病例介绍:一名76岁男性,既往有右肩皮肤黑色素瘤病史,放射后的状态,以3个月的视力下降,偶尔疼痛和右眼飞蚊症就诊于眼科肿瘤诊所。初步检查显示右眼手部运动视力正常,眼压5毫米汞柱,因玻璃体出血看不到眼底。b线扫描未显示视网膜撕裂、视网膜脱离或眼内肿瘤。患者行右眼平面部玻璃体切除术,发现大量脉络膜增厚伴视网膜下黄色沉积物阻塞视神经头,最初与淋巴瘤有关。术后第一周,视力保持手部运动,眼底检查显示清晰的玻璃体和视网膜/脉络膜浸润,掩盖了视神经和黄斑。重复b超显示视网膜和脉络膜增厚伴渗出物。手术后的细胞学结果显示恶性细胞与黑色素瘤一致。患者接受了眼部放射线治疗,但最终进展为无光感视力。他目前正在接受姑息治疗的观察。结论:本病例强调了在黑色素瘤病史背景下保持高度怀疑转移的重要性,即使表现可能不典型。早期发现脉络膜转移可以及时干预,提高保留视力的机会。
{"title":"Metastatic Cutaneous Melanoma Presenting with Choroidal Metastasis Mimicking Lymphoma: A Case Report.","authors":"Laura E Drew-Bear, Allison Drummond, Crystal Truong, Komal Desai","doi":"10.1159/000544926","DOIUrl":"10.1159/000544926","url":null,"abstract":"<p><strong>Introduction: </strong>Approximately 5% of patients with cutaneous melanoma develop distant metastases, and very rarely, can involve the eye and orbit. This case report discusses a patient with an unusual presentation of choroidal metastasis secondary to cutaneous melanoma.</p><p><strong>Case presentation: </strong>A 76-year-old man with a past medical history of cutaneous melanoma on the right shoulder status post radiation presented to the ocular oncology clinic with a 3-month history of decreased vision, occasional pain, and floaters in the right eye. Initial examination revealed a visual acuity of hand motion in the right eye, intraocular pressure of 5 mm Hg, and no view to the fundus due to vitreous hemorrhage. B-scan did not show a retinal tear, retinal detachment, or intraocular tumor. The patient underwent pars plana vitrectomy of the right eye where massive choroidal thickening with subretinal yellow deposits obstructing the optic nerve head was seen, initially concerning lymphoma. On postoperative week one, visual acuity remained hand motion and the fundus exam showed clear vitreous and retinal/choroidal infiltrates obscuring the optic nerve and macula. Repeat B-scan showed retinal and choroidal thickening with exudates. Cytology results from surgery later revealed malignant cells consistent with melanoma. The patient underwent ocular radiation but eventually progressed to no light perception visual acuity. He is currently under observation with the goal of palliative care.</p><p><strong>Conclusion: </strong>This case highlights the importance of maintaining a high level of suspicion for metastasis in the setting of melanoma history even when presentation can be atypical. Early recognition of choroidal metastasis allows for timely intervention, improving the chances of preserving vision.</p>","PeriodicalId":9635,"journal":{"name":"Case Reports in Ophthalmology","volume":"16 1","pages":"360-365"},"PeriodicalIF":0.5,"publicationDate":"2025-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12133125/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144214931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Delayed Onset of Central Serous Chorioretinopathy following Corticosteroid Treatment for Giant Cell Arteritis: A Case Report. 巨细胞动脉炎经皮质类固醇治疗后迟发性中心性浆液性脉络膜视网膜病变1例报告。
IF 0.5 Q4 OPHTHALMOLOGY Pub Date : 2025-04-23 eCollection Date: 2025-01-01 DOI: 10.1159/000546053
Bava Jeyanathan, Jonathan Micieli

Introduction: Central serous chorioretinopathy (CSCR) is a known complication of corticosteroid use, characterized by the accumulation of subretinal fluid (SRF), which can lead to changes in vision. Giant cell arteritis (GCA) is a systemic vasculitis that often necessitates high-dose corticosteroid treatment to prevent serious complications including permanent vision loss. Although the association between CSCR and corticosteroids is well established, its occurrence in patients diagnosed with GCA remains rarely reported in literature.

Case presentation: We present a case of a 71-year-old man who developed CSCR following 6 months of corticosteroid treatment for GCA. The patient presented with decreased vision in the left eye for 10 days, prompting ophthalmologic evaluation. Initial visual acuity (VA) was measured at 20/60, and OCT identified the presence of SRF, confirming CSCR as the underlying etiology. Following gradual tapering of his prednisone dosage, subsequent OCT confirmed significant reduction in SRF, with VA improving to 20/30 within 3 months.

Conclusion: This case highlights the importance of considering CSCR in the differential diagnosis of new or worsening visual symptoms in GCA patients receiving corticosteroids. The risk for corticosteroid-induced CSCR in these patients creates a diagnostic challenge, as worsening vision may be incorrectly attributed to disease progression rather than being recognized as a treatment-related adverse effect. This case emphasizes the importance of early recognition of CSCR and highlights the need for interdisciplinary collaboration between rheumatologists and ophthalmologists to ensure appropriate management for patients with GCA.

中心性浆液性脉络膜视网膜病变(CSCR)是一种已知的皮质类固醇使用并发症,其特征是视网膜下积液(SRF)积聚,可导致视力改变。巨细胞动脉炎(GCA)是一种全身性血管炎,通常需要大剂量皮质类固醇治疗,以防止包括永久性视力丧失在内的严重并发症。虽然CSCR和皮质类固醇之间的关系已经确立,但其在诊断为GCA的患者中的发生在文献中很少报道。病例介绍:我们报告了一例71岁的男性,在接受皮质类固醇治疗6个月后发生了CSCR。患者出现左眼视力下降10天,需要眼科检查。初始视力(VA)测量为20/60,OCT确定SRF的存在,确认CSCR是潜在的病因。随着泼尼松剂量的逐渐减少,随后的OCT证实SRF显著降低,VA在3个月内改善至20/30。结论:本病例强调了在接受皮质类固醇治疗的GCA患者新发或恶化视觉症状的鉴别诊断中考虑CSCR的重要性。这些患者发生皮质类固醇诱导的CSCR的风险给诊断带来了挑战,因为视力恶化可能被错误地归因于疾病进展,而不是被认为是与治疗相关的不良反应。该病例强调了早期识别CSCR的重要性,并强调了风湿病学家和眼科医生之间跨学科合作的必要性,以确保对GCA患者进行适当的管理。
{"title":"Delayed Onset of Central Serous Chorioretinopathy following Corticosteroid Treatment for Giant Cell Arteritis: A Case Report.","authors":"Bava Jeyanathan, Jonathan Micieli","doi":"10.1159/000546053","DOIUrl":"10.1159/000546053","url":null,"abstract":"<p><strong>Introduction: </strong>Central serous chorioretinopathy (CSCR) is a known complication of corticosteroid use, characterized by the accumulation of subretinal fluid (SRF), which can lead to changes in vision. Giant cell arteritis (GCA) is a systemic vasculitis that often necessitates high-dose corticosteroid treatment to prevent serious complications including permanent vision loss. Although the association between CSCR and corticosteroids is well established, its occurrence in patients diagnosed with GCA remains rarely reported in literature.</p><p><strong>Case presentation: </strong>We present a case of a 71-year-old man who developed CSCR following 6 months of corticosteroid treatment for GCA. The patient presented with decreased vision in the left eye for 10 days, prompting ophthalmologic evaluation. Initial visual acuity (VA) was measured at 20/60, and OCT identified the presence of SRF, confirming CSCR as the underlying etiology. Following gradual tapering of his prednisone dosage, subsequent OCT confirmed significant reduction in SRF, with VA improving to 20/30 within 3 months.</p><p><strong>Conclusion: </strong>This case highlights the importance of considering CSCR in the differential diagnosis of new or worsening visual symptoms in GCA patients receiving corticosteroids. The risk for corticosteroid-induced CSCR in these patients creates a diagnostic challenge, as worsening vision may be incorrectly attributed to disease progression rather than being recognized as a treatment-related adverse effect. This case emphasizes the importance of early recognition of CSCR and highlights the need for interdisciplinary collaboration between rheumatologists and ophthalmologists to ensure appropriate management for patients with GCA.</p>","PeriodicalId":9635,"journal":{"name":"Case Reports in Ophthalmology","volume":"16 1","pages":"372-376"},"PeriodicalIF":0.5,"publicationDate":"2025-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12136551/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144224405","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aqueous Humor Liquid Biopsy to Exclude Retinoblastoma for a Child with an Intraocular Mass. 儿童眼内肿块房水活检排除视网膜母细胞瘤。
IF 0.5 Q4 OPHTHALMOLOGY Pub Date : 2025-04-21 eCollection Date: 2025-01-01 DOI: 10.1159/000545924
Andrew J Nelson, Susanna Park, Marvin D Nelson, Jesse L Berry

Introduction: Intraocular masses in children may present diagnostic dilemmas when clinical examination and imaging are insufficient to diagnose or exclude retinoblastoma. Furthermore, direct biopsy is contraindicated because of the risk of tumor seeding in retinoblastoma. Recent research has shown that aqueous humor biopsy is a safe method of obtaining cell-free DNA which can be used to diagnose retinoblastoma with high sensitivity and specificity, which provides a significant benefit in cases when the diagnosis is otherwise unclear.

Case presentation: An 11-month-old female presented with poor visual behavior since birth and an intraocular mass in the left eye. Examination under anesthesia revealed a detached retina rolled into a stalk attached to the optic nerve in the right eye and a white retrolental mass with perfused vessels in the left eye. Magnetic resonance imaging demonstrated a heterogeneous mass filling the left globe with diffusion restriction and contract enhancement. Aqueous humor liquid biopsy was performed in both eyes with low DNA yield and no mutations associated with retinoblastoma were identified. The patient was observed with no interval change in examination for 6 months.

Conclusion: Aqueous humor liquid biopsy can be used to exclude a diagnosis of retinoblastoma in cases of pediatric intraocular mass with uncertain diagnosis.

当临床检查和影像学不足以诊断或排除视网膜母细胞瘤时,儿童眼内肿块可能会出现诊断困境。此外,由于视网膜母细胞瘤存在肿瘤生长的风险,直接活检是禁忌的。最近的研究表明房水活检是一种获得无细胞DNA的安全方法,可用于诊断视网膜母细胞瘤,具有高灵敏度和特异性,这在诊断不明确的情况下提供了显着的益处。病例介绍:一名11个月大的女婴,自出生以来表现为视觉行为不良,左眼有眼内肿块。麻醉下检查发现右眼视网膜脱离,视网膜卷成茎状附着于视神经,左眼视网膜后可见白色肿块伴灌注血管。磁共振成像显示左侧球内有非均匀肿块,扩散受限,收缩增强。对双眼进行房水活检,DNA产率低,未发现与视网膜母细胞瘤相关的突变。观察患者6个月检查间隔无变化。结论:房水活检可用于诊断不明确的儿童眼内肿块排除视网膜母细胞瘤的诊断。
{"title":"Aqueous Humor Liquid Biopsy to Exclude Retinoblastoma for a Child with an Intraocular Mass.","authors":"Andrew J Nelson, Susanna Park, Marvin D Nelson, Jesse L Berry","doi":"10.1159/000545924","DOIUrl":"10.1159/000545924","url":null,"abstract":"<p><strong>Introduction: </strong>Intraocular masses in children may present diagnostic dilemmas when clinical examination and imaging are insufficient to diagnose or exclude retinoblastoma. Furthermore, direct biopsy is contraindicated because of the risk of tumor seeding in retinoblastoma. Recent research has shown that aqueous humor biopsy is a safe method of obtaining cell-free DNA which can be used to diagnose retinoblastoma with high sensitivity and specificity, which provides a significant benefit in cases when the diagnosis is otherwise unclear.</p><p><strong>Case presentation: </strong>An 11-month-old female presented with poor visual behavior since birth and an intraocular mass in the left eye. Examination under anesthesia revealed a detached retina rolled into a stalk attached to the optic nerve in the right eye and a white retrolental mass with perfused vessels in the left eye. Magnetic resonance imaging demonstrated a heterogeneous mass filling the left globe with diffusion restriction and contract enhancement. Aqueous humor liquid biopsy was performed in both eyes with low DNA yield and no mutations associated with retinoblastoma were identified. The patient was observed with no interval change in examination for 6 months.</p><p><strong>Conclusion: </strong>Aqueous humor liquid biopsy can be used to exclude a diagnosis of retinoblastoma in cases of pediatric intraocular mass with uncertain diagnosis.</p>","PeriodicalId":9635,"journal":{"name":"Case Reports in Ophthalmology","volume":"16 1","pages":"366-371"},"PeriodicalIF":0.5,"publicationDate":"2025-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12136566/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144224404","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Late-Onset Subretinal Silicone Oil Migration through Optic Disc Coloboma. 迟发性视网膜下硅油通过视盘结肠瘤迁移。
IF 0.5 Q4 OPHTHALMOLOGY Pub Date : 2025-04-04 eCollection Date: 2025-01-01 DOI: 10.1159/000545661
Or Shmueli, Tareq Jaouni

Introduction: This report describes a case of late onset subretinal silicone oil migration in an eye with congenital optic disc coloboma and its treatment.

Case presentation: A 15-year-old male with a history of left eye congenital optic disc coloboma and amblyopia presented with a third recurrence of retinal detachment (RD) with proliferative vitreoretinopathy. The patient underwent PPV, subretinal fluid drainage through a peripheral retinotomy, silicone oil tamponade, and endolaser around the coloboma and retinotomy. The retina re-attached successfully. However, 14 months postoperatively examination revealed high intraocular pressure (IOP) of 33 mm Hg and a sub-macular bubble of silicone oil was evident. The patient underwent sub-macular silicone oil removal.

Conclusion: Here we describe the unique late-onset subretinal migration of intravitreal silicone oil following RD repair in an eye with optic disc coloboma in association with raised IOP. This case demonstrates potential mechanisms of subretinal silicone oil migration through the coloboma that serves as a passage and an increased IOP, which drives the oil from the vitreous to the subretinal space.

简介:本报告报告一例先天性视盘结肠瘤伴迟发型视网膜下硅油移位及治疗。病例介绍:一名15岁男性,有左眼先天性视盘缺损和弱视病史,第三次复发视网膜脱离(RD)伴增生性玻璃体视网膜病变。患者接受了PPV,视网膜下液引流,周围视网膜切开,硅油填塞,结肠瘤周围激光和视网膜切开。视网膜成功地重新附着。然而,术后14个月检查显示高眼压(IOP) 33毫米汞柱,黄斑下有明显的硅油泡。患者行黄斑下硅油去除术。结论:在此,我们描述了视盘缺损伴IOP升高的眼RD修复后玻璃体内硅油独特的晚发性视网膜下迁移。本病例证明了视网膜下硅油通过结肠迁移的潜在机制,结肠作为通道并增加IOP,从而驱动油从玻璃体到视网膜下间隙。
{"title":"Late-Onset Subretinal Silicone Oil Migration through Optic Disc Coloboma.","authors":"Or Shmueli, Tareq Jaouni","doi":"10.1159/000545661","DOIUrl":"https://doi.org/10.1159/000545661","url":null,"abstract":"<p><strong>Introduction: </strong>This report describes a case of late onset subretinal silicone oil migration in an eye with congenital optic disc coloboma and its treatment.</p><p><strong>Case presentation: </strong>A 15-year-old male with a history of left eye congenital optic disc coloboma and amblyopia presented with a third recurrence of retinal detachment (RD) with proliferative vitreoretinopathy. The patient underwent PPV, subretinal fluid drainage through a peripheral retinotomy, silicone oil tamponade, and endolaser around the coloboma and retinotomy. The retina re-attached successfully. However, 14 months postoperatively examination revealed high intraocular pressure (IOP) of 33 mm Hg and a sub-macular bubble of silicone oil was evident. The patient underwent sub-macular silicone oil removal.</p><p><strong>Conclusion: </strong>Here we describe the unique late-onset subretinal migration of intravitreal silicone oil following RD repair in an eye with optic disc coloboma in association with raised IOP. This case demonstrates potential mechanisms of subretinal silicone oil migration through the coloboma that serves as a passage and an increased IOP, which drives the oil from the vitreous to the subretinal space.</p>","PeriodicalId":9635,"journal":{"name":"Case Reports in Ophthalmology","volume":"16 1","pages":"331-335"},"PeriodicalIF":0.5,"publicationDate":"2025-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12077865/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144076242","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
From Retinal Vasculitis to Stroke, from Systemic Findings to Diagnosis, the Necessity of Multidisciplinary Management in Behçet's Disease: A Case Report. 从视网膜血管炎到中风,从系统发现到诊断,behet病多学科管理的必要性:一个病例报告。
IF 0.5 Q4 OPHTHALMOLOGY Pub Date : 2025-04-04 eCollection Date: 2025-01-01 DOI: 10.1159/000545635
Sayena Jabbehdari, Anthony Oganov, Sami H Uwaydat

Introduction: Behçet's disease (BD) is a rare, chronic multisystem disorder characterized by occlusive vasculitis, which can present with a variety of systemic and ocular manifestations. The diagnosis of BD is often challenging, particularly in populations with low prevalence. Retinal vasculitis and stroke can be key indicators, and the early involvement of a multidisciplinary team is essential for accurate diagnosis and management to prevent long-term complications.

Case presentation: A 40-year-old African American female presented with vision changes in her left eye and a history of multiple strokes. Examination revealed retinal ischemia and vasculitis, raising suspicion of an underlying systemic condition. Extensive workup for infectious and inflammatory causes was negative. As her condition progressed, the patient developed genital ulcers, prompting further investigation. A biopsy of the genital ulcer confirmed BD, and a multidisciplinary approach involving ophthalmology, rheumatology, and neurology was initiated. The patient was treated with high-dose corticosteroids, immunosuppressive therapy, and intravitreal corticosteroids, leading to stabilization of her ocular and systemic symptoms. Despite her history of stroke, the collaboration between specialties facilitated better management of her condition and prevention of further complications.

Conclusion: It is crucial to include BD as a potential diagnosis in cases of ophthalmic or systemic vasculitis, even in regions and populations with low prevalence. Early referral to a rheumatologist for cases of vasculitis and timely collaboration are essential for accurate diagnosis, prevention of systemic complications, and appropriate management.

behet病(BD)是一种罕见的慢性多系统疾病,以闭塞性血管炎为特征,可表现为多种全身和眼部表现。双相障碍的诊断通常具有挑战性,特别是在低患病率人群中。视网膜血管炎和中风可能是关键指标,多学科团队的早期介入对于准确诊断和管理以预防长期并发症至关重要。病例介绍:一名40岁非裔美国女性,左眼视力改变,有多次中风病史。检查显示视网膜缺血和血管炎,引起对潜在全身疾病的怀疑。广泛的感染和炎症检查均为阴性。随着病情的发展,患者出现生殖器溃疡,需要进一步调查。生殖器溃疡的活检证实了BD,并启动了包括眼科、风湿病学和神经病学在内的多学科方法。患者接受大剂量皮质类固醇、免疫抑制治疗和玻璃体内皮质类固醇治疗,眼部和全身症状稳定。尽管她有中风史,但专科之间的合作有助于更好地管理她的病情并预防进一步的并发症。结论:在眼科或全身性血管炎病例中,即使是在低患病率的地区和人群中,将BD作为潜在的诊断是至关重要的。血管炎病例的早期转诊和及时合作对于准确诊断、预防全身并发症和适当管理至关重要。
{"title":"From Retinal Vasculitis to Stroke, from Systemic Findings to Diagnosis, the Necessity of Multidisciplinary Management in Behçet's Disease: A Case Report.","authors":"Sayena Jabbehdari, Anthony Oganov, Sami H Uwaydat","doi":"10.1159/000545635","DOIUrl":"https://doi.org/10.1159/000545635","url":null,"abstract":"<p><strong>Introduction: </strong>Behçet's disease (BD) is a rare, chronic multisystem disorder characterized by occlusive vasculitis, which can present with a variety of systemic and ocular manifestations. The diagnosis of BD is often challenging, particularly in populations with low prevalence. Retinal vasculitis and stroke can be key indicators, and the early involvement of a multidisciplinary team is essential for accurate diagnosis and management to prevent long-term complications.</p><p><strong>Case presentation: </strong>A 40-year-old African American female presented with vision changes in her left eye and a history of multiple strokes. Examination revealed retinal ischemia and vasculitis, raising suspicion of an underlying systemic condition. Extensive workup for infectious and inflammatory causes was negative. As her condition progressed, the patient developed genital ulcers, prompting further investigation. A biopsy of the genital ulcer confirmed BD, and a multidisciplinary approach involving ophthalmology, rheumatology, and neurology was initiated. The patient was treated with high-dose corticosteroids, immunosuppressive therapy, and intravitreal corticosteroids, leading to stabilization of her ocular and systemic symptoms. Despite her history of stroke, the collaboration between specialties facilitated better management of her condition and prevention of further complications.</p><p><strong>Conclusion: </strong>It is crucial to include BD as a potential diagnosis in cases of ophthalmic or systemic vasculitis, even in regions and populations with low prevalence. Early referral to a rheumatologist for cases of vasculitis and timely collaboration are essential for accurate diagnosis, prevention of systemic complications, and appropriate management.</p>","PeriodicalId":9635,"journal":{"name":"Case Reports in Ophthalmology","volume":"16 1","pages":"317-322"},"PeriodicalIF":0.5,"publicationDate":"2025-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12077862/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144076241","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transsphenoidal Optic Canal Decompression to Manage a Venous Malformation of the Optic Canal: A Case Report. 经蝶窦视神经管减压术治疗视神经管静脉畸形1例。
IF 0.5 Q4 OPHTHALMOLOGY Pub Date : 2025-04-03 eCollection Date: 2025-01-01 DOI: 10.1159/000545542
Khizar Rana, David Curragh, Valerie Juniat, Sandy Patel, James Slattery, Dinesh Selva

Introduction: Intracanalicular vascular malformations are rare. This report describes a case of compressive optic neuropathy secondary to an intracanalicular venous malformation managed with endoscopic transsphenoidal optic canal decompression.

Case presentation: A 43-year-old female presented with an 18-month history of painless vision loss secondary to an intracanalicular venous malformation causing compressive optic neuropathy. Ophthalmic examination showed reduced visual acuity and color vision, relative afferent pupillary defect, and optic disc pallor. Imaging findings were consistent with a slow-flow vascular malformation. An endoscopic transsphenoidal optic canal decompression was performed. The lesion was found to be wrapping around the optic nerve. At follow-up after 1 year, visual acuity had improved along with restoration of full color vision and visual fields.

Conclusion: This case highlights the successful use of endoscopic transsphenoidal optic canal decompression to treat compressive optic neuropathy caused by an intracanalicular venous malformation.

导管内血管畸形是罕见的。本报告描述了一例压迫性视神经病变继发于小管内静脉畸形,经内镜下经蝶窦视神经管减压治疗。病例介绍:一名43岁女性,有18个月的无痛性视力丧失史,继发于静脉管内畸形,引起压缩性视神经病变。眼科检查显示视力和色觉下降,瞳孔相对传入缺损,视盘苍白。影像学表现符合慢流血管畸形。内镜下经蝶窦视神经管减压。病变被发现包裹在视神经周围。随访1年后,视力明显改善,全彩色视觉和视野恢复。结论:本病例强调内镜下经蝶窦视神经管减压术成功治疗由管内静脉畸形引起的压迫性视神经病变。
{"title":"Transsphenoidal Optic Canal Decompression to Manage a Venous Malformation of the Optic Canal: A Case Report.","authors":"Khizar Rana, David Curragh, Valerie Juniat, Sandy Patel, James Slattery, Dinesh Selva","doi":"10.1159/000545542","DOIUrl":"https://doi.org/10.1159/000545542","url":null,"abstract":"<p><strong>Introduction: </strong>Intracanalicular vascular malformations are rare. This report describes a case of compressive optic neuropathy secondary to an intracanalicular venous malformation managed with endoscopic transsphenoidal optic canal decompression.</p><p><strong>Case presentation: </strong>A 43-year-old female presented with an 18-month history of painless vision loss secondary to an intracanalicular venous malformation causing compressive optic neuropathy. Ophthalmic examination showed reduced visual acuity and color vision, relative afferent pupillary defect, and optic disc pallor. Imaging findings were consistent with a slow-flow vascular malformation. An endoscopic transsphenoidal optic canal decompression was performed. The lesion was found to be wrapping around the optic nerve. At follow-up after 1 year, visual acuity had improved along with restoration of full color vision and visual fields.</p><p><strong>Conclusion: </strong>This case highlights the successful use of endoscopic transsphenoidal optic canal decompression to treat compressive optic neuropathy caused by an intracanalicular venous malformation.</p>","PeriodicalId":9635,"journal":{"name":"Case Reports in Ophthalmology","volume":"16 1","pages":"313-316"},"PeriodicalIF":0.5,"publicationDate":"2025-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12064154/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143953651","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Case Reports in Ophthalmology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1